These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 7589072)

  • 101. An intracameral injection of antigen induces in situ chemokines and cytokines required for the generation of circulating immunoregulatory monocytes.
    Pais R; Bhowmick S; Chattopadhyay S; Lemire Y; Sharafieh R; Yadav R; O'Rourke J; Cone RE
    PLoS One; 2012; 7(8):e43182. PubMed ID: 22912822
    [TBL] [Abstract][Full Text] [Related]  

  • 102. In situ suppression of delayed-type hypersensitivity: another mechanism for sustaining the immune privilege of the anterior chamber.
    Benson JL; Niederkorn JY
    Immunology; 1991 Sep; 74(1):153-9. PubMed ID: 1937568
    [TBL] [Abstract][Full Text] [Related]  

  • 103. The role of antigen-presenting cells in the regulation of delayed-type hypersensitivity. I. Spleen dendritic cells.
    Morikawa Y; Furotani M; Kuribayashi K; Matsuura N; Kakudo K
    Immunology; 1992 Sep; 77(1):81-7. PubMed ID: 1398768
    [TBL] [Abstract][Full Text] [Related]  

  • 104. CD1d on antigen-transporting APC and splenic marginal zone B cells promotes NKT cell-dependent tolerance.
    Sonoda KH; Stein-Streilein J
    Eur J Immunol; 2002 Mar; 32(3):848-57. PubMed ID: 11870629
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Phenotypic and immunoregulatory characteristics of monocytic iris cells.
    Li X; Shen S; Urso D; Kalique S; Park SH; Sharafieh R; O'Rourke J; Cone RE
    Immunology; 2006 Apr; 117(4):566-75. PubMed ID: 16556271
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Ocular immune privilege and CTL tolerance.
    McKenna KC; Kapp JA
    Immunol Res; 2004; 29(1-3):103-12. PubMed ID: 15181274
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Anterior chamber-associated immune deviation elicited via primate eyes.
    Eichhorn M; Horneber M; Streilein JW; Lutjen-Drecoll E
    Invest Ophthalmol Vis Sci; 1993 Sep; 34(10):2926-30. PubMed ID: 8360025
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Anterior chamber associated immune deviation used as a neuroprotective strategy in rats with spinal cord injury.
    Pineda-Rodriguez B; Toscano-Tejeida D; García-Vences E; Rodriguez-Barrera R; Flores-Romero A; Castellanos-Canales D; Gutierrez-Ospina G; Castillo-Carvajal L; Meléndez-Herrera E; Ibarra A
    PLoS One; 2017; 12(11):e0188506. PubMed ID: 29190648
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Anterior chamber associated immune deviation: the privilege of immunity in the eye.
    Streilein JW
    Surv Ophthalmol; 1990; 35(1):67-73. PubMed ID: 2204129
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Allogeneic Sensitization and Tolerance Induction After Corneal Endothelial Cell Transplantation in Mice.
    Yamada J; Ueno M; Toda M; Shinomiya K; Sotozono C; Kinoshita S; Hamuro J
    Invest Ophthalmol Vis Sci; 2016 Sep; 57(11):4572-80. PubMed ID: 27603721
    [TBL] [Abstract][Full Text] [Related]  

  • 111. B-1 B cells mediate required early T cell recruitment to elicit protein-induced delayed-type hypersensitivity.
    Szczepanik M; Akahira-Azuma M; Bryniarski K; Tsuji RF; Kawikova I; Ptak W; Kiener C; Campos RA; Askenase PW
    J Immunol; 2003 Dec; 171(11):6225-35. PubMed ID: 14634139
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Evidence for multiple CD95-CD95 ligand interactions in anteriorchamber-associated immune deviation induced by soluble protein antigen.
    Kezuka T; Streilein JW
    Immunology; 2000 Mar; 99(3):451-7. PubMed ID: 10712676
    [TBL] [Abstract][Full Text] [Related]  

  • 113. The effects of glaucoma filtering surgery on anterior chamber-associated immune deviation and contribution of lymphatic drainage in rats.
    Lu H; Lu QJ; Fu T; Pan ZQ; Wang NL
    Eye (Lond); 2009 Jan; 23(1):215-21. PubMed ID: 18497832
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Capacity of simian virus 40 T antigen to induce self-tolerance but not immunological privilege in the anterior chamber of the eye.
    Ma D; Comerford S; Bellingham D; Sambrook J; Gething MJ; Alizadeh H; Anand R; Mellon J; Niederkorn JY
    Transplantation; 1994 Mar; 57(5):718-25. PubMed ID: 8140635
    [TBL] [Abstract][Full Text] [Related]  

  • 115. CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site.
    Sonoda KH; Exley M; Snapper S; Balk SP; Stein-Streilein J
    J Exp Med; 1999 Nov; 190(9):1215-26. PubMed ID: 10544194
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Immune amplification of murine CD8 suppressor T cells induced via an immune-privileged site: quantifying suppressor T cells functionally.
    Sharafieh R; Lemire Y; Powell S; O'Rourke J; Cone RE
    PLoS One; 2011; 6(8):e22496. PubMed ID: 21829628
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Role of inflammatory cytokines in induction of anterior chamber-associated immune deviation.
    Okamoto S; Streilein JW
    Ocul Immunol Inflamm; 1998 Mar; 6(1):1-11. PubMed ID: 9798188
    [TBL] [Abstract][Full Text] [Related]  

  • 118. The eye's view of antigen presentation.
    Streilein JW; Masli S; Takeuchi M; Kezuka T
    Hum Immunol; 2002 Jun; 63(6):435-43. PubMed ID: 12039518
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Neural control of ocular immune privilege.
    Streilein JW; Okamoto S; Sano Y; Taylor AW
    Ann N Y Acad Sci; 2000; 917():297-306. PubMed ID: 11268357
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Therapies based on principles of ocular immune privilege.
    Zhang-Hoover J; Stein-Streilein J
    Chem Immunol Allergy; 2007; 92():317-327. PubMed ID: 17264506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.